A detailed history of Bank Of America Corp transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 105,672 shares of ATOS stock, worth $171,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,672
Previous 79,931 32.2%
Holding current value
$171,188
Previous $143,000 12.59%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.03 - $2.1 $26,513 - $54,056
25,741 Added 32.2%
105,672 $125,000
Q1 2024

May 15, 2024

BUY
$0.8 - $1.89 $62,252 - $147,070
77,815 Added 3677.46%
79,931 $143,000
Q4 2023

Feb 14, 2024

BUY
$0.63 - $0.98 $199 - $309
316 Added 17.56%
2,116 $1,000
Q2 2023

Aug 14, 2023

SELL
$0.6 - $1.28 $1,518 - $3,238
-2,530 Reduced 58.43%
1,800 $2,000
Q1 2023

May 12, 2023

SELL
$0.59 - $0.91 $21,077 - $32,509
-35,725 Reduced 89.19%
4,330 $3,000
Q4 2022

Feb 10, 2023

BUY
$0.5 - $1.01 $20,027 - $40,454
40,054 Added 4005400.0%
40,055 $21,000
Q3 2022

Nov 14, 2022

SELL
$0.82 - $1.14 $39 - $54
-48 Reduced 97.96%
1 $0
Q2 2022

Aug 12, 2022

SELL
$0.85 - $1.28 $40,635 - $61,192
-47,807 Reduced 99.9%
49 $0
Q1 2022

May 16, 2022

SELL
$1.11 - $1.74 $88,785 - $139,177
-79,987 Reduced 62.57%
47,856 $60,000
Q4 2021

Feb 08, 2022

BUY
$1.6 - $3.27 $57,822 - $118,174
36,139 Added 39.41%
127,843 $205,000
Q3 2021

Nov 15, 2021

BUY
$2.89 - $6.4 $37,226 - $82,438
12,881 Added 16.34%
91,704 $298,000
Q2 2021

Sep 13, 2021

BUY
$1.52 - $8.62 $119,810 - $679,454
78,823 New
78,823 $498,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $205M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.